Performance of LLY Eli Lilly and Company | 49.9% in 12m
Compare LLY with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Eli Lilly and Company with its related Sector/Index XLV
Performance Duell LLY vs XLV
| TimeFrame | LLY | XLV |
|---|---|---|
| 1 Week | 0.44% | -0.25% |
| 1 Month | 1.08% | -1.71% |
| 3 Months | -3.53% | 1.61% |
| 6 Months | 19.8% | 10.92% |
| 12 Months | 49.9% | 20.88% |
| YTD | 57.9% | 11.05% |
| Rel. Perf. 1m | 0.31 | |
| Rel. Perf. 3m | 0.35 | |
| Rel. Perf. 6m | 0.68 | |
| Rel. Perf. 12m | 2.27 | |
| Spearman 1m | 0.63 | -0.373 |
| Spearman 3m | 0.31 | 0.464 |
Is Eli Lilly and Company a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Eli Lilly and Company (XETRA:LLY) is currently (October 2024)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 46.38 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LLY as of October 2024 is 1195.40. This means that LLY is currently undervalued and has a potential upside of +40.87% (Margin of Safety).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LLY as of October 2024 is 1195.40. This means that LLY is currently undervalued and has a potential upside of +40.87% (Margin of Safety).
Is LLY a buy, sell or hold?
Eli Lilly and Company has no consensus analysts rating. ValueRay therefore judges the recommendation based on the last 12 Month Returns of 49.91%.
In compare to Health Care Sector SPDR Fund, LLY made 29.03% more over the last 12 months. Due to the outperformance, it is recommend to buy LLY.
In compare to Health Care Sector SPDR Fund, LLY made 29.03% more over the last 12 months. Due to the outperformance, it is recommend to buy LLY.
Values above 0%: LLY is performing better - Values below 0%: LLY is underperforming
Compare LLY with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.64% | -2.66% | 2.69% | 9.78% |
| US NASDAQ 100 | QQQ | 0.71% | -2.82% | 4.06% | 10.42% |
| US Dow Jones Industrial 30 | DIA | -1.39% | -2.87% | 4.22% | 17.06% |
| German DAX 40 | DBXD | -0.54% | -3.26% | 10.73% | 20.02% |
| UK FTSE 100 | ISFU | -0.05% | 1.80% | 6.27% | 25.71% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 8.87% | -15.85% | 11.43% | 38.57% |
| Hongkong Hang Seng | HSI | 5.37% | -8.01% | -4.08% | 38.84% |
| Japan Nikkei 225 | EXX7 | 0.89% | -3.07% | 16.55% | 26.94% |
| India NIFTY 50 | INDA | 1.77% | 3.88% | 9.23% | 21.81% |
| Brasil Bovespa | EWZ | 0.86% | 7.01% | 22.56% | 48.48% |
LLY Eli Lilly and Company vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.40% | -2.40% | 5.87% | 12.29% |
| Consumer Discretionary | XLY | -0.22% | -2.03% | 3.96% | 17.82% |
| Consumer Staples | XLP | -0.63% | 2.24% | 6.50% | 24.50% |
| Energy | XLE | 2.17% | -3.08% | 21.90% | 46.03% |
| Financial | XLF | -3.90% | -4.33% | -1.10% | -0.37% |
| Health Care | XLV | 0.69% | 2.79% | 8.85% | 29.03% |
| Industrial | XLI | -1.66% | -4.48% | 4.35% | 7.07% |
| Materials | XLB | -1.63% | -3.13% | 9.50% | 18.20% |
| Real Estate | XLRE | -2.91% | 1.65% | -6.72% | 9.49% |
| Technology | XLK | 0.58% | -4.09% | 3.65% | 8.52% |
| Utilities | XLU | -3.28% | -2.65% | -9.28% | 4.88% |
| Aerospace & Defense | XAR | -3.32% | -5.92% | -3.84% | 7.06% |
| Biotech | XBI | -2.76% | 2.70% | 2.30% | 1.29% |
| Homebuilder | XHB | -2.92% | -1.08% | -3.94% | -26.67% |
| Retail | XRT | -4.02% | -1.67% | 8.33% | 16.10% |
Does Eli Lilly and Company outperform its market, is LLY a Sector Leader?
Yes, over the last 12 months Eli Lilly and Company (LLY) made 49.91%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 20.88%.
Over the last 3 months LLY made -3.53%, while XLV made 1.61%.
Yes, over the last 12 months Eli Lilly and Company (LLY) made 49.91%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 20.88%.
Over the last 3 months LLY made -3.53%, while XLV made 1.61%.
| Period | LLY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 1.08% | -1.71% | 3.74% |
| 3 Months | -3.53% | 1.61% | 4.88% |
| 12 Months | 49.91% | 20.88% | 40.13% |